1. Home
  2. OCUL vs PLGO Comparison

OCUL vs PLGO Comparison

Compare OCUL & PLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$10.04

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

PLGO

Pelagos Insurance Capital Limited Common Shares

N/A

Current Price

$23.84

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OCUL
PLGO
Founded
2006
N/A
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
OCUL
PLGO
Price
$10.04
$23.84
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$23.56
N/A
AVG Volume (30 Days)
2.1M
383.8K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,990,000.00
N/A
Revenue This Year
$7.93
N/A
Revenue Next Year
$96.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.48
N/A
52 Week Low
$6.23
$20.85
52 Week High
$16.44
$26.34

Technical Indicators

Market Signals
Indicator
OCUL
PLGO
Relative Strength Index (RSI) 60.72 41.82
Support Level $9.24 N/A
Resistance Level $9.93 $26.06
Average True Range (ATR) 0.40 0.84
MACD 0.19 -0.29
Stochastic Oscillator 76.54 51.55

Price Performance

Historical Comparison
OCUL
PLGO

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: